Icahn School of Medicine at Mount Sinai

Predicting cisplatin tolerability in older adults with head and neck cancer – Insights for improved chemoradiation outcomes (2025) Rühle A, Weymann M, Behrens M, Olbrich J, Kut C, Marschner SN, Haderlein M, et al. Journal article Long-Term, Patient-Level Analysis of Radiofrequency Renal Denervation in the SYMPLICITY Clinical Trial Program (2025) Mahfoud F, Townsend RR, Kandzari DE, Mancia G, Whitbourn R, Lauder L, Bhatt DL, et al. Journal article Hyperreactive B cells instruct their elimination by T cells to curb autoinflammation and lymphomagenesis. (2025) Diehl C, Soberón V, Baygün S, Chu Y, Mandelbaum J, Kraus L, Engleitner T, et al. Journal article Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk Group (2025) Katsivelos N, Spyrou N, Weber D, Vasova I, Ayuk F, Choe H, Hogan W, et al. Journal article Integrating genetic regulation and single-cell expression with GWAS prioritizes causal genes and cell types for glaucoma (2024) Hamel AR, Yan W, Rouhana JM, Monovarfeshani A, Jiang X, Mehta PA, Advani J, et al. Journal article Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy (2024) Saalfeld FC, Möller J, Christopoulos P, Wenzel C, Rasokat A, Wang XA, Vathiotis I, et al. Journal article Optical coherence tomography predictors of clinical outcomes after stent implantation: the ILUMIEN IV trial (2024) Landmesser U, Ali ZA, Maehara A, Matsumura M, Shlofmitz RA, Guagliumi G, Price MJ, et al. Journal article Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials (2024) Louis E, Schreiber S, Panaccione R, Bossuyt P, Biedermann L, Colombel JF, Parkes G, et al. Journal article Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease (2024) Peyrin-Biroulet L, Chapman JC, Colombel JF, Caprioli F, D’Haens G, Ferrante M, Schreiber S, et al. Journal article The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD (2024) DeFilipp Z, Kim HT, Spyrou N, Katsivelos N, Kowalyk S, Eng G, Kasikis S, et al. Journal article